Effectiveness of regular reporting of spirometric results combined with a smoking cessation advice by a primary care physician on smoking quit rate in adult smokers: A randomized controlled trial. ESPIROTAB study

BMC Family Practice

Volumn 12, Issue , 2011, Pages

  Rodriguez Alvarez, Mar ^a,b   Torán Monserrat, Pere ^a,b   Mũoz Ortiz, Laura ^b   Negrete Palma, Antonio ^a,b   Montero Alia, Juan José ^a   Jiménez González, Mercedes ^a   Zurilla Leonarte, Elena ^a   Marina Ortega, Victoria ^a   Olle Borque, Montserrat ^a   Valentin Moya, Esther ^a   Cortada Cabrera, Anna ^a   Tena Domingo, Alexis ^a   Martínez González, Silvia ^a   Vila Palau, Victoria ^a   Ramos Ordõez, Adriana ^a   Rotllant Estelrich, Guida ^a   Forcada Vega, Carme ^a   Borrell Thiá, Eullia ^a,b  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIRECTIVE COUNSELING; HUMAN; MULTICENTER STUDY; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; SPIROMETRY; STATISTICS;

ADULT; DIRECTIVE COUNSELING; HUMANS; PRIMARY HEALTH CARE; SMOKING; SMOKING CESSATION; SPIROMETRY;

EID: 79959609888     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-12-61     Document Type: Article

References (31)

1. The global burden of disease: 2004 update. CD Mathers, Geneva: World Health Organization 2008
2. Projections of global mortality and burden of disease from 2002 to 2030. CD Mathers D Roncar, PLOS Medicine 2006 3 2011 30 (Pubitemid 44875937)
3. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. CJ Murray AD Lopez, Lancet 1997 349 1347 52 10.1016/S0140-6736(96)07494-6 9149696 (Pubitemid 27197536)
4. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. R Pauwels A Buist P Calverley C Jenkins S Hurd, Am J Respir Crit Care Med 2001 163 1256 76 11316667 (Pubitemid 32378468)
5. Recommendations for the care of the patient with chronic obstructive pulmonary disease. JL Álvarez-Sala E Cimas J Masa M Miravitlles J Molina K Naberan P Simonet J Viejo, Arch Bronconeumol 2001 37 269 78 11481057 (Pubitemid 34036509)
6. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. V Sobradillo M Miravitlles CA Jiménez R Gabriel JL Viejo JF Masa L Fernández Fau C Villasante, Arch Bronconeumol 1999 35 159 66 10330536
7. COPD: reflections on cause and course. A Pacheco, Arch Bronconeumol 2001 37 457 8 11734130
8. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC Multicentre Epidemiological Study. V Sobradillo-Pẽa M Miratvitlles R Gabriel CA Jiménez-Ruiz C Villasante JF Masa JL Viejo L Fernández-Fau, Chest 2000 118 981 9 10.1378/chest.118.4.981 11035667
9. Chronic obstructive pulmonary disease: on an exponential curve of progress. JE Heffner, Respir Care 2002 47 586 607 11988127
10. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. M Miravitlles JB Soriano F García- Río L Mũoz E Duran-Tauleria G Sanchez V Sobradillo J Ancochea, Thorax 2009 64 863 8 10.1136/thx.2009.115725 19553233
11. Cost of Chronic Bronchitis and COPD. A 1-year follow-up study. M Miravitlles C Murio T Guerreo R Gisbert the DAFNE Study Group, Chest 2003 123 784 91 10.1378/chest.123.3.784 12628879 (Pubitemid 36315494)
12. Few smokers develop COPD. Why? NM Siafakas EG Tzortzaki, Respir Med 2002 96 615 24 10.1053/rmed.2002.1318 12195843
13. Early detection and management of COPD. What you can do to reduce the impact of this disabling disease. DE Doherty, Postgrad Med 2002 111 41 50 12082920
14. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. CP Van Schayck JMC Loozen E Wagena RP Akkermans JG Wesseling, BMJ 2002 324 1370 4 10.1136/bmj.324.7350.1370 12052807
15. Early detection of COPD in a high-risk population using spirometric screening. J Zielĩski M Bednarek the Know the Age of Your Lung Study Group, Chest 2001 119 731 36 10.1378/chest.119.3.731 11243950 (Pubitemid 32197641)
16. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute, Worl Health Organixation. Global Initiative for Chronic Obstructive Lung Disease (GOLD), NHLBI/WHO workshop report National Institutes of Health (NIH) Publication N°. 2701A 2001 http://www.goldcopd.com
17. Pla de Salut de Catalunya 2002-2005. Generalitat de Catalunya. Departament de Sanitat i Seguretat Social, Barcelona: Departament de Sanitat i Seguretat Social 2003
18. Encuesta Nacional de Salud. Instituto Nacional de Estadística, 2006 http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/home.htm [Last access: April 2008]
19. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilatador on the rate decline of FEV1. The Lung Health Study. NR Anthonisen JE Connett JP Kiley MD Altose WC Bailey AS Buist WA Conway PL Enright RE Kanner P O'Hara GR Owens PD Scanlon DP Tashkin RA Wise the Lung Health Study Research Group, JAMA 1994 272 1497 1505 10.1001/jama.272.19.1497 7966841
20. Smoking reduction, smoking cessation and mortality: a 16-year follow-up of 19732 men and women from the Copenhagen Cente for Prospective Population Studies. NS Godtfredsen C Holst E Prescott J Vestbo M Osler, Am J Epidemiol 2002 156 994 1001 10.1093/aje/kwf150 12446255 (Pubitemid 35396928)
21. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. P Tonnensen L Carrozzi KO Fargerström C Gratziou C Jimenez-Ruiz S Nardini G Viegi C Lazzaro IA Campell E Dagli R West, Eur Resp J 2007 29 390 417 (Pubitemid 46231920)
22. Análisis de tabaquismo en Espãa a la luz de los resultados del estudio IBERPOC. CA Jimenez Ruiz V Sobradillo Pẽa M Miravitlles R Gabriel C Villasante JF Masa L Fernández Fau JL Viejo Bãuelos, Prev Tab 2000 2 189 193
23. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease. EJ Wagena MPA Zeegers CP Van Schayck EFM Wouters, Drug Saf 2003 26 381 403 10.2165/00002018-200326060-00002 12688831 (Pubitemid 36560712)
24. The promotion of the tobacco abandonment: a revision of the strategies. O Sol-Morales, Agència d'Avaluaciá de Tecnologia i Recerca Mèdiques 2003 21714017
25. Individual behavioral counseling for smoking cessation. T Lancaster LF Stead, Cochrane Database Syst Rev 2002 3 CD001292
26. An analysis of the effectiveness of interventions intended to help people stop smoking. M Law JL Tang, Arch Inter Med 1995 155 1933 41 10.1001/archinte.155.18.1933
27. Tobacco detoxication at a primary care clinic: efficacy of medical counselling, the minimal intervention and nicotine replacement therapy at one-year control. M Torrecilla M Barrueco JA Maderuelo CA Jiménez MD Plaza MA Hernández, Aten Primaria 2001 27 629 36 11412554
28. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. D Gorecka M Bednarek A Nowinski E Puscinska A Goljan-Geremek J Zielinski, Chest 2003 123 1916 23 10.1378/chest.123.6.1916 12796168 (Pubitemid 36706712)
29. Biomedical risk assessment as an aid for smoking cessation. R Bize B Burnand Y Mueller M Rège Walther J Cornuz, Cochrane Database of Systematic Reviews 2009 2 Art. No.: CD004705
30. Effect on smoking quit rate of telling patients their lung age: the Step 2 quit randomised controlled trial. G Parkes M Griffin R Dent, BMJ 2008 336 598 600 10.1136/bmj.39503.582396.25 18326503 (Pubitemid 351439517)
31. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. TJ Wilt D Niewoehner RL Kane R MacDonald AM Joseph, Nicotine Tob Res 2007 9 1 21 32 10.1080/14622200601078509 17365733 (Pubitemid 47009041)